{"disease":{"id":"cancer-of-the-prostate","name":"cancer of the prostate"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07109427","title":"Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System","phase":"NA","overall_status":"RECRUITING","enrollment_count":40000,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT06825715","title":"Multilevel Intervention for Precision Oncology","phase":"NA","overall_status":"RECRUITING","enrollment_count":2653,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT02003924","title":"Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1401,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT07086651","title":"A Study to Learn About Two Medicines (Apalutamide and Enzalutamide) in People With Metastatic Castration-sensitive Prostate Cancer (mCSPC)","phase":"","overall_status":"COMPLETED","enrollment_count":1300,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT02319837","title":"Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1068,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03235687","title":"Decision Impact Trial of the ExoDx Prostate (IntelliScore)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":1000,"lead_sponsor_name":"Exosome Diagnostics, Inc.","has_results":false},{"nct_id":"NCT07028853","title":"This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04017325","title":"European Randomised Study of TOOKAD® Soluble for Prostate Cancer vs Active Surveillance. Post Study Follow-up","phase":"","overall_status":"COMPLETED","enrollment_count":374,"lead_sponsor_name":"Steba Biotech S.A.","has_results":false},{"nct_id":"NCT00643617","title":"CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy Dosimetry","phase":"NA","overall_status":"COMPLETED","enrollment_count":307,"lead_sponsor_name":"Accuray Incorporated","has_results":true},{"nct_id":"NCT04183699","title":"Optimizing the Number of Systematic COres During a MRI Target Biopsy","phase":"NA","overall_status":"RECRUITING","enrollment_count":265,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT03392428","title":"A Trial of 177Lu-PSMA617 Theranostic Versus Cabazitaxel in Progressive Metastatic Castration Resistant Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Australian and New Zealand Urogenital and Prostate Cancer Trials Group","has_results":false},{"nct_id":"NCT02640534","title":"Investigation of Metformin in Patients With Castration Resistant Prostate Cancer in Combination With Enzalutamide vs. Enzalutamide Alone","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":169,"lead_sponsor_name":"Swiss Cancer Institute","has_results":false},{"nct_id":"NCT04028479","title":"The Registry of Oncology Outcomes Associated With Testing and Treatment","phase":"","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"Taproot Health","has_results":false},{"nct_id":"NCT03517488","title":"A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Xencor, Inc.","has_results":false},{"nct_id":"NCT07084779","title":"Investigation of Impact of AI on Prostate Cancer Workflow","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Case Comprehensive Cancer Center","has_results":false},{"nct_id":"NCT03939689","title":"I-131-1095 Radioligand Plus Enzalutamide vs Enzalutamide for mCRPC That Progressed During Abiraterone (ARROW).","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":120,"lead_sponsor_name":"Progenics Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03454451","title":"CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Corvus Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04586543","title":"Clinical Trial of Selegiline Plus Docetaxel for the Treatment of Metastatic, Castrate-resistant Prostate Adenocarcinoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":110,"lead_sponsor_name":"László Mangel","has_results":false},{"nct_id":"NCT05252390","title":"NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":82,"lead_sponsor_name":"Nuvation Bio Inc.","has_results":false},{"nct_id":"NCT03849469","title":"A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":78,"lead_sponsor_name":"Xencor, Inc.","has_results":false},{"nct_id":"NCT04541225","title":"Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid Tumors","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":74,"lead_sponsor_name":"Nuvation Bio Inc.","has_results":false},{"nct_id":"NCT03960788","title":"Gadoxetate Sodium Enhanced MRI as a Biomarker for Aggressive Prostate Cancer","phase":"EARLY_PHASE1","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"University of Cincinnati","has_results":false},{"nct_id":"NCT03629756","title":"A Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced Malignancies","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Arcus Biosciences, Inc.","has_results":false},{"nct_id":"NCT01655836","title":"High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer","phase":"PHASE1","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":42,"lead_sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University","has_results":false},{"nct_id":"NCT07221825","title":"Low-Count Quantitative SPECT for Men Treated With Radium-223","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":38,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT02632669","title":"Hemi-Ablative Prostate Brachytherapy","phase":"NA","overall_status":"COMPLETED","enrollment_count":31,"lead_sponsor_name":"Royal Surrey County Hospital NHS Foundation Trust","has_results":false},{"nct_id":"NCT03124433","title":"Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Singapore General Hospital","has_results":false},{"nct_id":"NCT05628363","title":"Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate Cancer","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT03191968","title":"Prostate Cancer Survivors and Exercise and Behavioral Counseling","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"University of Illinois at Urbana-Champaign","has_results":false},{"nct_id":"NCT02349139","title":"Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate Cancer","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":27,"lead_sponsor_name":"Asana BioSciences","has_results":false},{"nct_id":"NCT03653819","title":"High Intensity Interval Training (HIIT) for Patients With Cancer-related Lymphedema in the Lower Limbs","phase":"NA","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Herlev and Gentofte Hospital","has_results":false},{"nct_id":"NCT02215161","title":"Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate Cancer","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":14,"lead_sponsor_name":"University of California, San Francisco","has_results":true},{"nct_id":"NCT01303705","title":"Anti-OX40, Cyclophosphamide (CTX) and Radiation in Patients With Progressive Metastatic Prostate Cancer","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Providence Health & Services","has_results":false},{"nct_id":"NCT03432897","title":"BrUOG 337: Olaparib Prior to Radical Prostatectomy For Advanced Prostate Cancer Defects in DNA Repair Genes","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":1,"lead_sponsor_name":"Brown University","has_results":true},{"nct_id":"NCT02355054","title":"Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access Study","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Washington University School of Medicine","has_results":false}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}